5 Results for "

BTK-IN-11

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "BTK-IN-11" in MCE Product Catalog:

Cat. No.: HY-147581
CAS No.: 2765852-46-6
Target:  

Btk

Research Areas:  

Inflammation/Immunology Cancer

BTK-IN-11 is a potent inhibitor of BTK. BTK plays an important role in signaling mediated by B cell antigen receptor (BCR) and Fcγreceptor (FcγR) in B cells and myeloid cells, respectively. BTK-IN-11 has the potential for the research of related diseases, especially autoimmune diseases, inflammatory diseases or cancer (extracted from patent WO2022063101A1, compound Z2) .
loading...
    loading...
Cat. No.: HY-176381
CAS No.: 2250382-80-8
Research Areas:  

Cancer

BTK ligand 11-alcohol-PEG6-azido is a synthesized E3 ligase ligand-linker conjugate that can be used in the synthesis of PROTACs, such as TDP-43 degrader-1 (HY-122828) .
loading...
    loading...
Cat. No.: HY-159947
CAS No.: 2736508-94-2
Target:  

PROTACs Btk

Research Areas:  

Cancer

PROTAC BTK Degrader-11 is a PROTAC degrader that can break down BTK, with a DC50 of 1.7 nM. PROTAC BTK Degrader-11 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-159956
CAS No.: 2736510-62-4
Research Areas:  

Cancer

BTK-IN-39 (0204) is a PROTAC target protein ligand that can be used to synthesize PROTAC BTK Degrader-11 (HY-159947) .
loading...
    loading...
Cat. No.: HY-168314
Research Areas:  

Cancer

BTK ligand 11 is a PROTAC target protein ligand that can be used to synthesize BCPyr (HY-142621) .
loading...
    loading...